Atlas Private Wealth Management’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-235
Closed -$84K 185
2021
Q1
$84K Sell
235
-13
-5% -$4.18K 0.05% 158
2020
Q4
$80K Hold
248
0.06% 162
2020
Q3
$67K Hold
248
0.05% 164
2020
Q2
$65K Hold
248
0.05% 176
2020
Q1
$56K Hold
248
0.05% 172
2019
Q4
$75K Buy
+248
New +$68.2K 0.06% 176

Other funds holding ELV

Atlas Private Wealth Management's ELV Position: Q2 2021 in Review

Atlas Private Wealth Management sold out of Elevance Health (ELV) in Q2 2021, closing a stake of 235 shares — an estimated $84K sold.

Atlas Private Wealth Management first reported a position in ELV in Q4 2019 and held it in 6 quarters. The position peaked at $84K in Q1 2021. 1,234 funds tracked by Wall St. Rank hold ELV as of Q2 2021.

  • Atlas Private Wealth Management reported no remaining Elevance Health position as of Q2 2021 after selling out during the quarter.
  • Atlas Private Wealth Management sold 235 Elevance Health shares in Q2 2021, an estimated $84K.
  • Atlas Private Wealth Management first reported a position in Elevance Health in Q4 2019 and held it in 6 quarters.
  • Atlas Private Wealth Management's Elevance Health position peaked at $84K in Q1 2021.
  • 1,234 funds tracked by Wall St. Rank held Elevance Health as of Q2 2021.

Based on Atlas Private Wealth Management's 13F filing for Q2 2021, filed 5 Aug 2021.